News & Trends - Pharmaceuticals
FINALISTS revealed – Health Industry Hub Awards 2023
We are thrilled to announce the FINALISTS for the Health Industry Hub Catalysts for Change Awards, as we approach the much-anticipated Awards ceremony on 1st November, where the WINNERS will crowned.
The Awards recognise and celebrate the MOST VIEWED vodcasts and TOP podcasts featuring leaders and change-makers who have captivated our audience across the healthcare sector, including the pharma, medtech, diagnostics and biotech industries. These remarkable individuals and organisations that inspire us to challenge the status quo and embark on a purposeful journey to reimagine healthcare.
FINALISTS
At Health Industry Hub, we believe in the power of collective engagement and the strength of our diverse audience. That’s why we are thrilled that once again YOU, our incredible Health Industry Hub audience from the pharma, medtech, diagnostics and biotech sectors, are serving as the esteemed judges for the prestigious Catalysts for Change Awards 2023. Your active participation across all our digital and social media channels is shaping the destiny of these Awards as we analyse the overall engagement data.
A huge congratulations to all the FINALISTS (in alphabetical order in each category)
Outstanding Policy Conversations
- Australian Private Hospitals Association (APHA)
- Edwards Lifesciences
- J&J MedTech
- Medicines Australia-Patient Voice Initiative
Advocacy Champion
- Gilead-Pink Hope-Professor Fran Boyle
- hearts4heart-Dr Michael Davis
- Medical Technology Association of Australia (MTAA)
- Varian-Lung Foundation Australia
Excellence in Collaboration
- Amgen-Bridge Program (QUT)
- Bayer-Prostate Cancer Foundation of Australia (PCFA)
- Novartis-Monash Uni-Telstra Health
- Stryker-A/Prof Laetitia de Villiers
Excellence in Digital Health
- AbbVie
- Pen CS
- Viatris
Excellence in Innovation
- Bayer Radiology
- Janssen
- Roche Diagnostics
ESG Champion
- Organon-J&J MedTech
- Pfizer
- Sanofi-Philips
Inspirational Leadership
- AbbVie
- Amgen
- Merck
Outstanding Medical Conversations
- AstraZeneca-Australian Diabetes Society (ADS)
- Bristol Myers Squibb (BMS)
- Medical Affairs Professionals of Australasia (MAPA)-Medicines Australia
STEM Champion
- Merck
- Noxopharm
- Organon-NYSF
Visionary Leadership
- BeiGene
- Boehringer Ingelheim
- Medtronic
- Sanofi
- Viatris
Corporate Communications Team of the Year
- Janssen
- Medtronic
- Roche
Corporate Communications Individual of the Year
- Alicia Campagnolo – Viatris
- Alison Miller-Swan – Stryker
- Emma Boscheinen – BMS
- Susannah Wade – Gilead
PR Agency Individual of the Year
- Joni Thomes – Palin Communications
- Kirsten Bruce – VIVA! Communications
- Tanya West – Weber Shandwick
PR Agency Team of the Year
- Palin Communications
- WE Communications
Event Information
Date: Wednesday, 1st November 2023
Time: 6pm – 9:30pm Venue: Dockside, The Balcony Level, Cockle Bay Wharf, Darling Harbour
Keynote Speakers: Dr Daniel Nour – Cardiologist, Founder of Street Side Medics & NSW Young Australian of the Year 2022 & Michelle Lee – The first Australian woman to row any ocean solo More…
Awards Ceremony Tickets: Book your tickets here by 11 October to ensure relevant representation of your organisation on the Awards night
Add to Calendar
Office 365 • Outlook Web • Outlook • Google • Apple
2022 Winners
Cardinal Health, Merck Healthcare, Patient Voice Initiative, Gilead Sciences, Bristol Myers Squibb, Johnson & Johnson MedTech, Pfizer, Medtronic, AbbVie, Sanofi, Viatris, hearts4heart, Medical Affairs Professionals of Australasia, Research Australia, Paras and Partners and Hunton Executive More…
Mark your calendars for 1st November as we crown the WINNERS!
Thank you to Health Industry Hub Awards’
GOLD SPONSORS
News & Trends - Pharmaceuticals
Clinicians shift stance, join calls for PBS subsidy of obesity and weight-loss medicines
Over a third of Australian adults live with obesity, and the National Obesity Strategy estimates the direct and indirect costs […]
MoreNews & Trends - Pharmaceuticals
Astellas secures new indication for prostate cancer drug
Astellas Xtandi (enzalutamide) is now TGA registered for a new indication for patients with non-metastatic hormone-sensitive prostate cancer (nmHSPC) with […]
MoreNews & Trends - MedTech & Diagnostics
Stakeholder calls intensify as government stalls on genetic discrimination ban
Calls have intensified for the federal government to honour its commitment to outlaw genetic discrimination in life insurance, as stakeholders […]
MoreNews & Trends - MedTech & Diagnostics
Pressure mounts to expand home-based therapies in kidney disease: World Kidney Day
As Australia marks World Kidney Day, the stark reality is that one in three adults is at risk of chronic […]
More